AstraZeneca
AZN
$68.90
Share price
1.58%
Change (1 day)
5.48%
Change (1 year)
Categories
AstraZeneca (AZN) - Total assets
Total assets on the balance sheet as of June 2023 : $96.54 B
According to AstraZeneca's latest financial reports the company's total assets are $96.54 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
AstraZeneca - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $96.48 B | -8.43% |
| 2021-12-31 | $105.36 B | 57.9% |
| 2020-12-31 | $66.72 B | 8.72% |
| 2019-12-31 | $61.37 B | 1.2% |
| 2018-12-31 | $60.65 B | -4.27% |
| 2017-12-31 | $63.35 B | 1.32% |
| 2016-12-31 | $62.52 B | 4% |
| 2015-12-31 | $60.12 B | 2.61% |
| 2014-12-31 | $58.59 B | 4.82% |
| 2013-12-31 | $55.89 B | 4.42% |
| 2012-12-31 | $53.53 B | 1.33% |
| 2011-12-31 | $52.83 B | -5.87% |
| 2010-12-31 | $56.12 B | 2.2% |
| 2009-12-31 | $54.92 B | 16.98% |
| 2008-12-31 | $46.95 B | -2.1% |
| 2007-12-31 | $47.95 B | 60.22% |
| 2006-12-31 | $29.93 B | 20.5% |
| 2005-12-31 | $24.84 B | -3.17% |
| 2004-12-31 | $25.65 B | 8.82% |
| 2003-12-31 | $23.57 B | 9.2% |
| 2002-12-31 | $21.58 B | -18.37% |
| 2001-12-31 | $26.44 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $195.96 B | 102.99% | 🇺🇸 USA |
 Novartis NVS | $110.97 B | 14.95% | 🇨🇭 Switzerland |
 Pfizer PFE | $195.61 B | 102.62% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.79 B | -23.56% | 🇺🇸 USA |
 Eli Lilly LLY | $54.81 B | -43.22% | 🇺🇸 USA |
 Sanofi SNY | $136.23 B | 41.11% | 🇫🇷 France |
 Biogen BIIB | $25.15 B | -73.94% | 🇺🇸 USA |
 Merck MRK | $107.79 B | 11.66% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $93.48 B | -3.16% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.00 B | -22.31% | 🇬🇧 UK |